SUPPLEMENTARY MATERIAL

Published: 7 June 2024| Version 1 | DOI: 10.17632/f29jwbgh7j.1
Contributors:
Lindsay S. Ackerman, Bethanee Schlosser, Tianyu Zhan, Vimal H. Prajapati, Scott Fretzin, Hidetoshi Takahashi, Xiaohong Huang, Heidi S. Camp, Alexa B. Kimball

Description

Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo controlled study

Files

Categories

Hidradenitis Suppurativa

Licence